Location: Bardstown
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Bardstown
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine Phase 3 · Physicians to Children & Adolescents, PSC (Kentucky Pediatri · Kallyope Inc. · NCT07674654 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer NA · CommonSpirit Saint Joseph Hospital - Bardstown · Alliance for Clinical Trials in Oncology · NCT07091617 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Phase 2/Phase 3 · CommonSpirit Saint Joseph Hospital - Bardstown · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc Phase 3 · CommonSpirit Saint Joseph Hospital - Bardstown · Alliance for Clinical Trials in Oncology · NCT06632327 Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age Phase 3 · Kentucky Pediatric Research- Site Number : 8400036 · Sanofi · NCT07348692 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol Phase 3 · CommonSpirit Saint Joseph Hospital - Bardstown · Alliance for Clinical Trials in Oncology · NCT06876714 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL Phase 3 · CommonSpirit Saint Joseph Hospital - Bardstown · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S Phase 3 · CommonSpirit Saint Joseph Hospital - Bardstown · Canadian Cancer Trials Group · NCT06592924 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M Phase 2 · Flaget Memorial Hospital · SWOG Cancer Research Network · NCT05806515 E-Mindfulness Approaches for Living After Breast Cancer Phase 3 · CommonSpirit Saint Joseph Hospital - Bardstown · NRG Oncology · NCT06748222 Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adoles Phase 3 · Kentucky Pediatric/ Adult Research · Pfizer · NCT07660198 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects Phase N/A · CommonSpirit Saint Joseph Hospital - Bardstown · Alliance for Clinical Trials in Oncology · NCT04242095 A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission o Phase 3 · Kentucky Pediatric Research Center · Hoffmann-La Roche · NCT06094010 Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials NA · Flaget Memorial Hospital · Eastern Cooperative Oncology Group · NCT05108298 A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants Phase 3 · Kentucky Pediatric/ Adult Research · Pfizer · NCT07573462 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial Phase 3 · Flaget Memorial Hospital · ECOG-ACRIN Cancer Research Group · NCT04566328 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg Phase 3 · CommonSpirit Saint Joseph Hospital - Bardstown · Alliance for Clinical Trials in Oncology · NCT05677490 An Internet-based Program to Help Cancer Survivors Manage Pain NA · Flaget Memorial Hospital · Wake Forest University Health Sciences · NCT04462302 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps NA · CommonSpirit Saint Joseph Hospital - Bardstown · NRG Oncology · NCT05080673 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers Phase 2 · Flaget Memorial Hospital · SWOG Cancer Research Network · NCT04205968 Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program Phase 3 · CommonSpirit Saint Joseph Hospital - Bardstown · Alliance for Clinical Trials in Oncology · NCT05008848 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head Phase 2 · Flaget Memorial Hospital · ECOG-ACRIN Cancer Research Group · NCT02734537 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Phase 3 · Flaget Memorial Hospital · SWOG Cancer Research Network · NCT03418961 Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays NA · CommonSpirit Saint Joseph Hospital - Bardstown · Alliance for Clinical Trials in Oncology · NCT07283939 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic NA · Flaget Memorial Hospital · SWOG Cancer Research Network · NCT03723928 A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07717879 Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo Phase 2 · CommonSpirit Saint Joseph Hospital - Bardstown · National Cancer Institute (NCI) · NCT03866382 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Phase 3 · CommonSpirit Saint Joseph Hospital - Bardstown · National Cancer Institute (NCI) · NCT04267848 Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD Phase 4 · Kentucky Pediatric/Adult Research · Supernus Pharmaceuticals, Inc. · NCT04781140 Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma Phase 3 · Flaget Memorial Hospital · ECOG-ACRIN Cancer Research Group · NCT03937635
Look up another city
Look up another condition